17 August 2023 - The Health Technology Assessment of medicines is performed separately at the country level with some differences, but Italy, France, and Germany have implemented price and reimbursement systems strongly focused on the added therapeutic value. 

This study investigates the level of agreement on added therapeutic value assessments by Agenzia Italiana del Farmaco (AIFA), Haute Autorité de Santé (HAS), and Gemeinsamer Bundesausschuss (G-BA).

Read International Journal of Technology Assessment in Health Care article